medigraphic.com
SPANISH

Revista del Hospital Juárez de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 3

<< Back Next >>

Rev Hosp Jua Mex 2007; 74 (3)

Guide for the follow-up of patients with ferropenic anemia

Safrazian N, Castillo HC, Lara PE
Full text How to cite this article

Language: Spanish
References: 11
Page: 191-197
PDF size: 73.64 Kb.


Key words:

Anemia, hemoglobin, iron of plasma, ferrous sofate, iron polymaltose complex.

ABSTRACT

Among the diverse type of anemia, ferropenic anemia distinguishes itself by its presence in all groups of age, which are attended by diverse specialists in addition to hematologists, pediatricians, gynecologists, nutritionists, surgeons, etcetera. Pathogenenesis: Because of the role that iron plays in the respiratory chain, it is fundamental for aerobic metabolic process that take place to obtain energy. Its deficit diminishes the vital capacity of the cells as well as the organism as a whole, thus lowering the quality of life. The clinical manifestations of this pathology are unspecific (asthenia, adynamic, dizziness, mild depression, muscular fatigue) which makes timely attention to these patients difficult. As a result, doctors prescribe vitamins and minerals as food supplements. In the best of cases this causes a slight improvement of the patients, but delays and complicates a correct and timely diagnosis. Such a diagnosis, in the event that it come about, is able to provide important data about illnesses that could put the life of the patient in danger, although they are curable. To maintain the vital balance of the patient, it is very important to look for hemorrhagic danger points caused by gastritis, gastric ulcers, haemorrhoids, miomas, polymenorrea, etcetera. A special mention is due for pregnant women, as the majority show signs of anemia (low haemoglobin) while only a few have a deficit of iron. In the absence of a correct diagnosis, many of the latter are trated with medications based on iron, without this being necessary.


REFERENCES

  1. Tratamiento de la anemia ferropénica. Recomendaciones Internacionales. Clin Farm I Terap Moscú: Medicina 2001; 1: 40-1.

  2. Rumyanzev A, Tokarev Yu, Anemias de los niños: diagnósticos y tratamientos. Moscú: MAXPress; 2000.

  3. Linch S, Lipshiz D. Enfermedades de la sangre de pacientes de la tercera edad. Moscú: Medicina 1989: 14-35.

  4. 4. Buitron R, Safrazian N, Piñera F, Camarena J, Licea J. Deshidratación y alteración en parámetros hematológicos en niños de 10-12 años que practican fútbol americano. 6º Congreso de Investigación en Medicina, México, D.F. 2004.

  5. Vorobiev AI. Manual of hematology. Moscú: Newdiamed: 2002.

  6. Not T, Horvath K, Hill I, Partanen J, Hammed A, Magazzu G. Celiac disease risk in the USA: high prevalence of antiendomysium antibodes in healthy blood donors. Scan J of Gastroenterol 1998; 33: 494-8.

  7. Safrazian N, Gama J, Licea J, Lara E. Tratamiento de anemia ferropénica en mujeres deportistas. Rimeder 2005; 6: 24-9.

  8. Vorobiev PA. El síndrome anémico en la práctica clínica. Moscú: Newdiamed; 2001.

  9. Idelson L. Manual de Anemias Hipocrómicas. Moscú: Medicina; 1981.

  10. Tuomainen TP, Nyyssonen K, Portkkla SE, Salonen J. Oral Supplementation with ferrous sofate bunt not with non-ionic iron polymatose complex increases the susceptibility of plasma liproteins to oxidation. Nutrizifion Research 1999; 19: 1121-32.

  11. Lozoff B, Jiménez E, Hagen J, Mollen E, Wolf AW. Poore behavioral and developmental outcome more than 10 years after treatment for iron deficiency ininfaney. Pediatrics 2000; 105: 1-11.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hosp Jua Mex. 2007;74